An interventional study of Full sternotomy and J-shaped mini-sternotomy in Ascending Aortic Aneurysm, sponsored by Tomsk Cardiology Research Institute. Recruiting at 1 site in Russia. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2026-02-05.
Sponsored by Tomsk Cardiology Research Institute · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
This study investigates outcomes after hemiarch repair in patients with chronic ascending aortic disease. The patients will be divided into two groups according to surgical approach: 100 patients will undergo hemiarch repair via full sternotomy (FS group) and 100 patients will receive hemiarch repair via J-shaped mini-sternotomy (MS group). Early and late outcomes will be recorded.
Imaging All aortic measurements will be assessed by electrocardiography-gated computed tomographic angiography. Postoperative computed tomography of the aorta will be performed within 2 weeks after surgery. Analysis will be performed using 64-slice scanner Discovery NM-CT 570c (GE Healthcare, Milwaukee, WI, USA) with spatial resolution of the angiographic phase ranging from 0.6 to 1.25 mm. All measurements will be taken always in the plane perpendicular to the manually corrected local aortic centre line. Ascending aortic diameter will be measured at the level of the pulmonary artery bifurcation. The maximum aortic diameter (mm) will be measured from the outer contours of the aortic wall. All images will be independently assessed by two experienced cardiologists.
Surgical technique The hemiarch repair is performed via a full sternotomy or J-shaped mini-sternotomy under mild-to-moderate hypothermia (28-30°C) and antegrade cerebral perfusion through the innominate artery with side graft. The distal aortic anastomosis is performed using an open anastomosis fashion and involved resection of the inferior portion of the aortic arch from the base of the innominate artery to the projection of the origin of the left subclavian artery. Near infrared spectroscopy (Invos 5100, Somanetics Corp., USA) is used for cerebral monitoring during the operation. When the target temperature is achieved, lower body circulatory arrest with antegrade cerebral perfusion is initiated. The distal aortic anastomosis is performed with a running 4/0 polypropylene suture with a Dacron graft. Proximal aortic reconstruction including Bentall procedure, David procedure, proximal aortic anastomosis, etc. are performed during the rewarming period. The patient is weaned from cardiopulmonary bypass when the body temperature reached 36°C. The sequence of the surgical steps during the operation are the same for all patients.
Follow-up Follow-up will be performed according to the institutional database supplemented by individual patient records. Data will be obtained via medical records of clinical encounters or phone calls with patients and/or relatives. Postoperative computed tomographic scans will be performed upon discharge, at 12 months from the last procedure and at 60 months thereafter.
22 studies on the registry are indexed under Aneurysm, Ascending Aorta; 11 are open to participants now.
This study's planned enrollment of 200 is above the median of 164 across 12 interventional studies indexed under Aneurysm, Ascending Aorta.
Browse Aneurysm, Ascending Aorta studies →Tomsk Cardiology Research Institute is the lead sponsor of 4 studies on the registry; 2 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
100 patients who will undergo hemiarch repair via full sternotomy
Procedure: Full sternotomy
100 patients who will undergo hemiarch repair via J-shaped mini-sternotomy
Procedure: J-shaped mini-sternotomy
hemiarch repair via full sternotomy
hemiarch repair via J-shaped mini-sternotomy
Early mortality
The difference in the incidence of early mortality between groups (p-value).
Time frame: during follow-up time - 60 months
Delirium (percent)
The difference in the incidence of delirium during follow-up (p-value).
Time frame: Perioperative/Periprocedural
Transient ischemic attack (percent)
The difference in the incidence of transient ischemic attack during follow-up (p-value).
Time frame: Perioperative/Periprocedural
Stroke (percent)
The difference in the incidence of stroke during follow-up (p-value).
Time frame: during follow-up time - 60 months
Respiratory failure (percent)
The difference in the incidence of respiratory failure during follow-up (p-value).
Time frame: Perioperative/Periprocedural
New arrythmia (percent)
The difference in the incidence of new arrythmia during follow-up (p-value).
Time frame: during follow-up time - 60 months
Pericardial effusion (percent)
The difference in the incidence of new arrythmia during follow-up (p-value).
Time frame: Perioperative/Periprocedural
Heart failure (percent)
The difference in the incidence of heart failure during follow-up (p-value).
Time frame: during follow-up time - 60 months
Myocardial infarction (percent)
The difference in the incidence of myocardial infarction during follow-up (p-value).
Time frame: during follow-up time - 60 months
Systemic embolism (percent)
The difference in the incidence of systemic embolism during follow-up (p-value).
Time frame: during follow-up time - 60 months
Acute kidney injury requiring renal replacement therapy (percent)
The difference in the incidence of renal replacement therapy during follow-up (p-value).
Time frame: during follow-up time - 60 months
Re-exploration rate (percent)
The difference in the incidence of re-operation for bleeding during follow-up (p-value).
Time frame: during follow-up time - 60 months
Plan to share: No
No publications or documents are linked to this record.
Started Jul 2022 (actual). Primary completion is estimated for Dec 2027, 65 months after the start.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Tomsk Cardiology Research Institute